Literature DB >> 20142181

The safety and feasibility of immediately returning patients transferred for primary percutaneous coronary intervention with ST-elevation myocardial infarction.

Alexis Matteau1, Stéphane Rinfret, Marc Dorais, Jacques Lelorier, François Reeves.   

Abstract

AIMS: To describe the safety of immediate retransfer to community hospitals following primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI). METHODS AND
RESULTS: In a cohort of 246 consecutive patients transferred to a tertiary institution who all underwent primary or rescue PCI, 166 (67%) were immediately retransferred back. The retransfer occurred only if they were haemodynamically stable and had undergone an uncomplicated procedure. In-hospital adverse events were assessed in each referral hospital. Patients had a mean age of 59 years, presented an anterior MI in 39%, and 91% were in Killip class 1. In this cohort, 75% of patients underwent primary PCI and 25% received rescue PCI. A transradial approach was used in 74% of patients. During ambulance transport back to the referral hospital, no adverse events occurred. In-hospital outcomes were favourable, with low death (2.4%), reinfarction (3.6%) and stroke (1.2%) rates. TIMI major bleeding occurred in 1.8% (catheter-related in 0.6%).
CONCLUSIONS: In this carefully selected population of STEMI patients, immediate retransfer to the referral hospital following primary or rescue PCI is feasible in more than 2/3 of patients and associated with a low risk of major clinical adverse events.

Entities:  

Mesh:

Year:  2009        PMID: 20142181     DOI: 10.4244/eijv5i5a96

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  1 in total

1.  Age and its relationship to acute coronary syndromes in the Saudi Project for Assessment of Coronary Events (SPACE) registry: The SPACE age study.

Authors:  Shukri M Al-Saif; Khalid F Alhabib; Anhar Ullah; Ahmed Hersi; Husam Alfaleh; Khalid Alnemer; Amir Tarabin; Ahmed Abuosa; Tarek Kashour; Mushabab Al-Murayeh
Journal:  J Saudi Heart Assoc       Date:  2011-10-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.